© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
The Hartford Healthcare Fund Class A (HGHAX) stock declined over -0.12%, trading at $41.59 on NASDAQ, down from the previous close of $41.64. The stock opened at $41.64, fluctuating between $41.59 and $41.64 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 41.64 | 41.64 | 41.59 | 41.59 | 0 |
| Sep 10, 2026 | 41.89 | 41.89 | 41.62 | 41.62 | 0 |
| Sep 09, 2026 | 42.13 | 42.13 | 41.89 | 41.89 | 0 |
| Sep 08, 2026 | 43.01 | 43.01 | 42.13 | 42.13 | 0 |
| Sep 04, 2026 | 43.44 | 43.44 | 43.01 | 43.01 | 0 |
| Sep 03, 2026 | 43.08 | 43.44 | 43.08 | 43.44 | 0 |
| Sep 02, 2026 | 43.08 | 43.42 | 43.08 | 43.42 | 0 |
| Sep 01, 2026 | 42.80 | 43.08 | 42.80 | 43.08 | 0 |
| Aug 31, 2026 | 42.91 | 42.91 | 42.80 | 42.80 | 0 |
| Aug 28, 2026 | 43.30 | 43.30 | 42.91 | 42.91 | 0 |
| Aug 27, 2026 | 43.78 | 43.78 | 43.30 | 43.30 | 0 |
| Aug 26, 2026 | 43.84 | 43.84 | 43.78 | 43.78 | 0 |
| Aug 25, 2026 | 43.84 | 44.18 | 43.84 | 44.18 | 0 |
| Aug 24, 2026 | 43.93 | 43.93 | 43.84 | 43.84 | 0 |
| Aug 21, 2026 | 43.40 | 43.93 | 43.40 | 43.93 | 0 |
| Aug 20, 2026 | 44.38 | 44.38 | 43.40 | 43.40 | 0 |
| Aug 19, 2026 | 42.76 | 44.38 | 42.76 | 44.38 | 0 |
| Aug 18, 2026 | 42.18 | 42.76 | 42.18 | 42.76 | 0 |
| Aug 17, 2026 | 42.18 | 42.21 | 42.18 | 42.21 | 0 |
| Aug 14, 2026 | 42.41 | 42.41 | 42.18 | 42.18 | 0 |
The fund's core objective is to achieve substantial growth in capital over an extended timeframe. Typically, at least 80% of its total assets are committed to equity investments in companies globally involved in the healthcare industry, with selections made by its sub-adviser, Wellington Management Company LLP. The investment strategy adopts a comprehensive view of the healthcare sector, encompassing a diverse range of enterprises. These may include, but are not limited to, firms specializing in pharmaceuticals, biotechnology, medical device manufacturing and distribution, healthcare service provision, managed health programs, health information technology, and nascent health-related segments.
| Employees | 0 |
| Beta | 0.61 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Financial Services |
| Industry | Asset Management |